- Home
- RVPH vs BATL Comparison
RVPH vs BATL Comparison
Compare RVPH & BATL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- BATL
- Stock Information
- Founded
- RVPH 2006
- BATL 1987
- Country
- RVPH United States
- BATL United States
- Employees
- RVPH N/A
- BATL N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- BATL Oil & Gas Production
- Sector
- RVPH Health Care
- BATL Energy
- Exchange
- RVPH Nasdaq
- BATL Nasdaq
- Market Cap
- RVPH 18.1M
- BATL 18.9M
- IPO Year
- RVPH N/A
- BATL N/A
- Fundamental
- Price
- RVPH $0.57
- BATL $1.38
- Analyst Decision
- RVPH Strong Buy
- BATL
- Analyst Count
- RVPH 6
- BATL 0
- Target Price
- RVPH $4.50
- BATL N/A
- AVG Volume (30 Days)
- RVPH 19.3M
- BATL 350.0K
- Earning Date
- RVPH 11-13-2025
- BATL 11-11-2025
- Dividend Yield
- RVPH N/A
- BATL N/A
- EPS Growth
- RVPH N/A
- BATL N/A
- EPS
- RVPH N/A
- BATL N/A
- Revenue
- RVPH N/A
- BATL $185,206,000.00
- Revenue This Year
- RVPH N/A
- BATL N/A
- Revenue Next Year
- RVPH N/A
- BATL N/A
- P/E Ratio
- RVPH N/A
- BATL N/A
- Revenue Growth
- RVPH N/A
- BATL N/A
- 52 Week Low
- RVPH $0.25
- BATL $1.00
- 52 Week High
- RVPH $4.28
- BATL $6.89
- Technical
- Relative Strength Index (RSI)
- RVPH 52.50
- BATL 67.97
- Support Level
- RVPH $0.42
- BATL $1.09
- Resistance Level
- RVPH $0.69
- BATL $1.20
- Average True Range (ATR)
- RVPH 0.11
- BATL 0.08
- MACD
- RVPH -0.02
- BATL 0.02
- Stochastic Oscillator
- RVPH 32.74
- BATL 74.51
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About BATL Battalion Oil Corporation
Battalion Oil Corp is an independent energy company focused on the acquisition, production, exploration, and development of onshore liquids-rich oil and natural gas assets in the U.S. Its properties and drilling activities are currently focused in the Delaware Basin.